FRAXA Research Foundation has awarded a $90,000 research grant to principal investigator Dr. Xinyu Zhao and postdoctoral fellow Dr. Minjie Shen at the University of Wisconsin. They are investigating whether drugs which boost mitochondria — which provide the energy for cells — could treat fragile X syndrome. Dr. Zhao explains in this video. With this award, FRAXA has funded almost $1 Million in Fragile X research at the University of Wisconsin!
Learn more about this grant:
[ Ссылка ]
FRAXA’s mission is to find effective treatments and ultimately a cure for Fragile X syndrome. We directly fund research grants and fellowships at top universities around the world. We partner with biomedical and pharmaceutical companies, large and small, to bridge the gap between research discoveries and actual treatments.
Treatments for Fragile X are likely to help people affected by autism, Alzheimer’s, and other brain disorders.
To learn more about FRAXA's Fragile X Syndrome research, to get involved with Fragile X awareness and events or to donate to FRAXA research, visit FRAXA.org
Let's Connect:
LinkedIn: [ Ссылка ]
Instagram: [ Ссылка ]
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]
Website: [ Ссылка ]
